A healthy heart and circulatory system are essential to good health. That's why at Abbott, we throw our hearts into advancing treatments for people with cardiovascular disease.
We focus on innovative technologies that can improve the way clinicians treat people with vascular diseases, irregular heartbeats and diseases of the heart's valves and other structures.
Visit www.cardiovascular.abbott for more information.
AMPLATZER™ PFO Occluder closes the patent foramen ovale (PFO) to reduce the risk of ischemic stroke, and is the leading device approved in the United States for PFO closure. It's been proven to reduce the risk of recurrent ischemic stroke in patients with a PFO over medical management alone.
AMPLATZER™ Amulet™ LAA Occluder closes the left atrial appendage (LAA) of the heart to reduce the risk of stroke in people with atrial fibrillation (irregular heartbeat) who cannot rely on blood thinners. The Amulet occluder device is currently available in many countries and under investigation in the U.S.
Our Portico™ transcatheter aortic valve treats aortic stenosis by replacing a diseased or damaged aortic heart valve without major surgery — providing an important option for people needing minimally invasive treatment. Available in Europe in four sizes, it is designed for control and ease of use and is fully repositionable and retrievable before being fully deployed. Portico valve offers precise placement for physicians, improving patient outcomes and is currently under investigation in the U.S.
And our innovative, first-in-class therapy MitraClip™. MitraClip — the first transcatheter mitral valve repair device — delivers a therapeutic option when no other option exists to treat mitral regurgitation, a common heart valve disease. Having been implanted in more than 60,000 people worldwide, MitraClip™ is a well-established therapy with a growing body of clinical and real-world experience.
Quadra Allure™ CRT-P and Quadra Assura™ CRT-D — our cardiac resynchronization therapy (CRT) devices — use leads to coordinate the rhythm of the heart’s ventricles, allowing it to beat more effectively. Leading the industry with the first available quadripolar pacing system, which uses four electrodes instead of the traditional two electrodes, Quadra Allure and Quadra Assura give doctors more options to effectively and efficiently manage heart failure.
Our CardioMEMS™ HF System is a pulmonary artery pressure monitoring sensor that allows physicians to proactively manage heart failure patients in an effort to keep them out of the hospital. CardioMEMS HF System is the only heart failure monitoring device that can detect changes in the pressure of blood flowing through the vessel between your heart and lungs. This information allows physicians to indicate worsening heart failure — even before you notice symptoms — and adjust medications, potentially preventing hospitalization.
HeartMate II™ and HeartMate 3™ left ventricle assist devices (LVAD) are mechanical heart pumps that help people when their hearts are too weak to pump blood on its own.
HeartMate II™ Left Ventricular Assist Device (LVAD) is a continuous-flow LVAD for both bridge-to-transplantation (short term) and destination therapy (long term) support. It is the first device of its kind to be approved by FDA for advanced heart failure, it and is the most studied and widely used LVAD with more than 27,000 implants.
HeartMate 3™ Left Ventricular Assist Device (LVAD) is the next generation in LVAD technology. Its centrifugal-flow design uses full MagLev™ (fully magnetically-levitated) flow technology, which allows the device's rotor to be "suspended" and precisely positioned by magnetic forces, reducing the trauma to blood passing through the pump, improving blood flow as well as a recipient's quality of life.
Our Confirm Rx™ Insertable Cardiac Monitor (ICM) detects irregular heartbeats. It's the first smartphone — compatible insertable cardiac monitor to support optimal diagnosis and treatment.
Abbott's line of MRI-labeled ICD (implantable cardioverter defibrillator) devices and CRT (cardiac resynchronization therapy) devices are all designed to send high-voltage electrical pulses to the heart if it's beating too quickly, giving doctors the ability to customize energy pulses to a patient’s needs and allowing full-body MRI scans.
The Fortify Assura™ ICD is built to treat patients who will need a high-energy shock to correct life-threatening events. It learns about and adapts to your heart, and recognizes the difference between life-threatening and normal heart rates.
The Merlin.net™ Patient Care Network and Merlin@home™ Transmitter work together to make up a communication system that wirelessly reads data from pacemakers or implantable cardioverter defibrillators (ICDs) and sends data to a secure website that medical professionals can access.
The Assurity MRI™ Pacemaker also sends low-voltage pulses to hearts beating too slowly. It's the smallest, longest-lasting wireless pacemaker that allows full-body MRI scans.
EnSite Precision™ Cardiac Mapping System allows physicians to capture more data in a shorter amount of time during cardiac mapping to support ablation procedures.
Advisor™ HD Grid Mapping Catheter offers a first-of-its kind electrode configuration for high density mapping. The catheter is used in conjuction with our EnSite Precision Cardiac Mapping System.
Our FlexAbility™ Ablation Catheter, Sensor Enabled™ and TactiCath™ Quartz Contact Force Ablation Catheter ablate tissue in the heart to restore the heart’s rhythm. Ablation is a procedure to remove a small area of heart tissue causing irregular heartbeats.
For coronary intervention, our extensive portfolio of drug-eluting stents, bare metal stents, coronary guidewires, balloon dilatation catheters, and guiding catheters and accessories help provide innovative, minimally invasive and cost-effective ways to treat coronary artery disease.
Products range from our XIENCE Family of Drug-Eluting Stents and TREK™ Balloon Dilation Catheters to coronary guidewires.
In peripheral intervention, our full range of products includes peripheral stents, peripheral guidewires, dilation catheters and guiding catheters. The range includes Absolute Pro™ Vascular Self-Expanding Stent System, Armada™ 35 Catheter and the Supera™ Peripheral Stent System.
CentriMag™ Acute Circulatory Support System
HeartMate II™ Left Ventricular Assist Device (LVAD)
HeartMate 3™ Left Ventricular Assist Device (LVAD)
Confirm Rx™ Insertable Cardiac Monitor
Absolute Pro™ Vascular Self-Expanding Stent System
AdvisorTM HD Grid Mapping Catheter Sensor Enabled™
Agilis™ NxT Steerable Introducers
EnSite Precision™ Cardiac Mapping System
FlexAbility™ Irrigated Ablation Catheter
FlexAbility™ Irrigated Ablation Catheter, Sensor EnabledTM
Supera™ Peripheral Stent System
TactiCath™ Quartz Contact Force Ablation Catheter
XIENCE Family of Drug-Eluting Stents
PERCLOSE PROGLIDE™ Suture-Mediated Closure System
STARCLOSE SE™ Vascular Closure System
Acculink™ Carotid Stent System
Links que o levam para sites fora dos websites globais da Abbott estão fora do controle da Abbott e a Abbott não é responsável pelo conteúdo de nenhum destes sites ou qualquer link que neles exista. A Abbott oferece estes links a você apenas como uma conveniência e a inclusão dos mesmos aqui não figura que estes sites têm o endosso da Abbott.
O website que você solicitou pode, ainda, não estar otimizado para a sua definição de tela.
SIGA A ABBOTT